Heart disease

Most Americans' hearts are older than their age

Higher heart age means higher risk of heart attacks and stroke ...

Ballooning platelets and the future of anti-thrombotic drugs

The research could ultimately lead to the development of new anti-thrombotic drugs to help manage heart disease and stroke ...

No Benefit to Prolonging Bivalirudin after PCI

LONDON, UK – Extending treatment with the anticoagulant bivalirudin for at least four hours after completion of percutaneous coronary intervention (PCI) does not improve outcomes compared to stopping the treatment immediately after the procedure, according to results from the MATRIX Treatment Duration trial. ... Full story

Alirocumab dramatically lowers cholesterol in familial hypercholesterolemia patients

London, UK – Alirocumab lowers cholesterol in patients with heterozygous familial hypercholesterolemia to levels unreachable with statins alone, according to results from four ODYSSEY trials presented at ESC Congress today.1 Final data from two of the studies (ODYSSEY FH I and II) are also published in European Heart Journal.2 This analysis in more than 1 250 patients showed that alirocumab rapidly lowered low density lipoprotein cholesterol (LDL-C) to unprecedented levels and the reductions were maintained long term. ... Full story

Dissolving Stent Compares Favourably Against Metal Stent in Japanese Trial

LONDON, England – A drug-eluting coronary stent, or “scaffold” made from bioresorbable material, showed similar efficacy and safety results compared to a metal stent in patients undergoing percutaneous coronary intervention (PCI), according to results of the ABSORB Japan study. ... Full story

EXAMINATION trial shows superiority of second generation drug-eluting stent at five years

London, UK – The EXAMINATION trial has demonstrated the superiority of a second generation drug-eluting stent over a bare-metal stent at five years in research presented at ESC Congress today.1 ... Full story

Treatment with life-saving drugs increases but still suboptimal in ischaemic heart disease

London, UK – Treatment with life-saving medications has increased over the past ten years in ischaemic heart disease but levels are still suboptimal, according to the first results of the Chronic Ischaemic Cardiovascular Disease (CICD) Pilot Registry presented today at ESC Congress 20151 and published in European Heart Journal.2 Statin prescriptions markedly increased from 48% to 67% before admission and reached 93% at discharge ... Full story

Central Sleep Apnoea Device Increases Mortality in Heart Failure

LONDON, UK – Adaptive servo-ventilation (ASV) therapy increases mortality and should not be used to treat central sleep apnoea in heart failure patients with reduced ejection fraction, the SERVE-HF trial shows. ... Full story

New cardiovascular disease death rates show stark inequalities between European countries

Diseases of the heart and blood vessels are the most common cause of death in Europe, resulting in over four million deaths a year (45% of all deaths) according to the latest available figures published today (Wednesday) in the European Heart Journal [1]. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 1375 | displaying: 1 - 10